Progression of coronary atherosclerosis in patients without standard modifiable risk factors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progression of coronary atherosclerosis in patients without standard modifiable risk factors

Published:2020-12 Issue: Volume:4 Page:100116
ISSN:2666-6677
Container-title:American Journal of Preventive Cardiology
language:en
Short-container-title:American Journal of Preventive Cardiology

Author:

Mazhar Jawad^ORCID,Figtree Gemma,Vernon Stephen T.,Galougahi Keyvan Karimi,Carlo Julie,Nissen Steven E.,Nicholls Stephen J.

Funder

National Health and Medical Research Council

Office of Health and Medical Research

Heart Research Australia

SV

AstraZeneca

Amgen Inc.

Anthera

Lilly

Novartis

The Medicines Company

Roche

Regeneron

Merck

Takeda

CSL Behring

Boehringer Ingelheim

Publisher

Elsevier BV

Reference30 articles.

1. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

2. AMERICAN association OF clinical endocrinologists and AMERICAN college OF endocrinology guidelines for management OF dyslipidemia and prevention OF cardiovascular disease;Jellinger;Endocr Pract : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.,2017

3. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective;Mahmood;Lancet,2014

4. Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors;Vernon;European journal of preventive cardiology,2017

5. ST-Segment-Elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors-how common are they, and what are their outcomes?;Vernon;Journal of the American Heart Association,2019

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and coronary artery lesion characteristics of young patients with ST elevation myocardial infarction and no standard modifiable risk factors;Catheterization and Cardiovascular Interventions;2024-09-09

2. Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors;Cardiovascular Diabetology;2024-07-23

3. Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors;2024-07-02

4. Ischaemia with no obstructive coronary arteries: a review with focus on the Asian population;Singapore Medical Journal;2024-07

5. No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis;Cardiovascular Intervention and Therapeutics;2024-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3